The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

NCT06856447 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Coenzyme Q10
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil (5-FU)
DRUG: 5-HT3 Antagonist
DRUG: Pantoprazole

Sponsor

toqa saad mohammed mohammed